Description
Pasireotide L-Aspartate Salt (CAS No. 396091-77-3) is a synthetic somatostatin analogue with high affinity for somatostatin receptor subtypes sst1, sst2, sst3, and sst5. It exhibits potent antisecretory, antiproliferative, and proapoptotic activities, making it valuable in research related to endocrine disorders, cancer, and metabolic diseases. Manufactured under GMP conditions with a purity of ??98.0%, it ensures consistency and reliability for experimental research. This product is intended strictly for laboratory research use and is not approved for clinical or therapeutic applications.

Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Pasireotide L-Aspartate Salt |
| CAS No. | 396091-77-3 |
| Purity | ??98.0% (GMP-grade) |
| Molecular Weight | Approx. 1,313.4 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in water, DMSO, or suitable buffers |
| Storage Conditions | Store at –20?°C; protect from light and moisture |
| Manufacturing Standard | GMP-compliant |
| Applications | Endocrine research, cancer studies, metabolic disease research |
| Regulatory Status | For laboratory research use only |
Mechanism of Action & Research Applications
Pasireotide L-Aspartate Salt functions as a somatostatin analogue with high affinity for multiple somatostatin receptor subtypes. Its mechanisms and applications in research include:
Antisecretory Activity: Inhibits the secretion of various hormones, including growth hormone, insulin, and glucagon.
Antiproliferative Effects: Suppresses cell proliferation in various tumor models.
Proapoptotic Activity: Induces apoptosis in certain cancer cell lines.
Endocrine Research: Useful in studies of pituitary and pancreatic functions.
Cancer Research: Investigates tumor growth inhibition and apoptosis mechanisms.
Metabolic Disease Research: Explores potential therapeutic strategies for metabolic disorders.
These actions make Pasireotide L-Aspartate Salt a versatile tool for experimental studies in endocrinology, oncology, and metabolic diseases.

Side Effects (For Reference Only in Models)
In preclinical models, Pasireotide L-Aspartate Salt is generally well tolerated. Observed effects may include transient changes in hormone levels or minor gastrointestinal responses. No clinical or human-use data is included; research is limited to laboratory studies.
Disclaimer
Pasireotide L-Aspartate Salt is intended strictly for laboratory research use only. It is not approved for clinical or therapeutic applications. Follow institutional safety protocols during handling.







Reviews
There are no reviews yet.